aplastic anemia | Page 12 | Aplastic Anemia & MDS International Foundation

aplastic anemia

Thomas LeBlanc, MD, MA

LeBlanc, Thomas
Duke Cancer Center

As a blood cancer specialist and also a palliative care physician, Dr. LeBlanc bring a different focus to cancer care. He is working hard to improve the treatment experience for patients who are living with blood cancers. By understanding your experience better, Dr. LeBlanc believes we can develop new ways to improve your quality of life, and provide additional support throughout your treatment and beyond.

Gabrielle Meyers, MD

Meyers, Gabrielle
Associate Professor of Medicine at the School of Medicine
OHSU Hospital

Dr. Meyers was born and raised in rural Northern California and traveled around the country during her medical training. She developed an interest in hematology and oncology during medical school, and pursued a fellowship in that field after her internal medicine residency.

John Mascarenhas, MD

Mascarenhas, John
Associate Professor of Medicine
The Mount Sinai Hospital

Dr. John Mascarenhas is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai (ISMMS) and a member of the Tisch Cancer Institute. Dr. Mascarenhas is the Director of the Adult Leukemia Program and Leader of Clinical Investigation within the Myeloproliferative Disorders Program at Mount Sinai, under the direction of Dr.

Navneet Majhail, MD, MS

Majhail, Navneet
Director of the Cleveland Clinic's Blood and Marrow Transplant Program
The Cleveland Clinic Taussig Cancer Institute

Dr Navneet Majhail, MD, MS is the Director of the Cleveland Clinic's Blood & Marrow Transplant Program. He serves as a Staff Physician with the Department of Hematology and Oncology at the Taussig Cancer Institute and is a Professor of Medicine with the Cleveland Clinic Lerner College of Medicine. Prior to joining the Cleveland Clinic, Dr Majhail has held appointments as Adjunct Associate Professor of Medicine with the University of Minnesota and as Medical Director Health Services Research at the National Marrow Donor Program, both in Minneapolis.

Andrew Lane, MD, PhD

Lane, Andrew
Director, Blastic Plasmacytoid Dendritic Cell Neoplasm Center
Dana-Farber Cancer Institute

Dr. Lane received his MD and PhD degrees from Washington University. He completed his residency in internal medicine at Brigham and Women's Hospital, and his fellowships in hematology and medical oncology at DFCI. His research focuses on developing new treatments for leukemia by studying the genetic changes that occur in cancer and how they alter the normal development of blood cells.